发明名称 DIRECT TRANSFUSIBLE O OR AH TYPE ERYTHROCYTE-CONTAINING COMPOSITION
摘要 PURPOSE: To obtain red blood cells which are converted to an H-antigen type to be used in the transfusion therapy by equilibrating B or A, B antigen type red blood cells to a specific pH, bringing the red blood cells into contact with α-galactositase to remove galactositase and equilibrating its pH to a specific value. CONSTITUTION: B or A, B antigen type red blood cells are equilibrated to a pH between 5.7-5.8 and the cells are brought into contact with α-galactosidase for a time enough to convert the B antigen to the H antigen in the red blood cells and the α-galactosidase is removed. Then, the treated red blood cells are equilibrated again to a pH of 7.2-7.4 whereby the objective directly transfusable O- or AH-type red blood cells which i) have no P1 antigenicity, ii) absorb and release oxygen in vivo, iii) have higher content of adenosine-5'- triphosphate than 90% content of naturally occurring B type red blood cells, iv) substantially contain no terminal chain-α-linked galactose trihexosylceramide and v) contain no type B antigenicity according to the analysis with the red blood cell coagulation reaction, are obtained.
申请公布号 JPH0228116(A) 申请公布日期 1990.01.30
申请号 JP19890144293 申请日期 1989.06.08
申请人 NEW YORK BLOOD CENTER INC 发明人 JIYATSUKU GOORUDOSUTAIN
分类号 A61K35/18;A61P7/00;A61P7/08 主分类号 A61K35/18
代理机构 代理人
主权项
地址
您可能感兴趣的专利